Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
    Log in
    Request to join
    Select an available language
    EN

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Abdul Latif Jameel Water and Food Systems Lab (J-WAFS)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Agriculture
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    See all

    Results (7)

    MIT study finds targets for a new tuberculosis vaccine

    MIT study finds targets for a new tuberculosis vaccine

    A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease.In the new study, a team of MIT biological engineers was able to identify a handful of immunogenic peptides, out of more than 4,000 bacterial proteins, that appear to stimulate a strong response from a type of T cells respons
    November 5, 2025
    Five with MIT ties elected to National Academy of Medicine for 2025

    Five with MIT ties elected to National Academy of Medicine for 2025

    On Oct. 20 during its annual meeting, the National Academy of Medicine announced the election of 100 new members, including MIT faculty members Dina Katabi and Facundo Batista, along with three additional MIT alumni.Election to the National Academy of Medicine (NAM) is considered one of the highest honors in the fields of health and medicine, recognizing individuals who have demonstrated outstandi
    October 22, 2025
    A new vaccine approach could help combat future coronavirus pandemics

    A new vaccine approach could help combat future coronavirus pandemics

    A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that could spill over from animals to humans.In addition to SARS-CoV-2, the virus that causes COVID-19, sarbecoviruses — a subgenus of coronaviruses — include the virus that led to the outbreak of the origi
    January 23, 2025
    A two-dose schedule could make HIV vaccines more effective

    A two-dose schedule could make HIV vaccines more effective

    One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines.Several years ago, MIT researchers showed that administering a series of escalating doses of an HIV vaccine over a two-week period could help overcome a part of that challenge by generating larger quantities of neutr
    September 20, 2024
    DNA particles that mimic viruses hold promise as vaccines

    DNA particles that mimic viruses hold promise as vaccines

    Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.The vaccine, which has been tested in mice, consists of a DNA scaffold that carries many copies of a viral antigen. This type of vaccine, known as a particulate vaccine, mimics the structure of
    January 30, 2024
    Vaccine delivers a boost to T cell therapy

    Vaccine delivers a boost to T cell therapy

    Engineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. However, it hasn’t worked as well for solid tumors.One reason for this lack of success is that the T cells target only one antigen (a target protein found on the tumors); if some of the tumor cells don’t express that antigen, they can escape the T cell attack.MIT researche
    July 5, 2023
    Immune system-stimulating nanoparticle could lead to more powerful vaccines

    Immune system-stimulating nanoparticle could lead to more powerful vaccines

    A common strategy to make vaccines more powerful is to deliver them along with an adjuvant — a compound that stimulates the immune system to produce a stronger response.Researchers from MIT, the La Jolla Institute for Immunology, and other institutions have now designed a new nanoparticle adjuvant that may be more potent than others now in use. Studies in mice showed that it significantly improved
    December 3, 2021
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    Coordinator@immunizeor.org
    Links
    • Immunize Oregon Website
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.